One of the six 2023 Chancellor’s Innovation Fund Awards will go to BME Associate Professor Ashley Brown. The Chancellor’s Innovation Fund (CIF) provides seed funding to a select few NC State research projects each year that have promise for market success. “The goal is to provide the critical funding needed to translate technologies to a point where a startup can be formed for commercialization or a license can be executed with an existing company,” says Wade Fulghum, assistant vice chancellor of the Office of Research Commercialization.
Prof. Brown’s CIF project is titled “Neonatal Derived Fibrin Nanoparticles to Promote Wound Healing.” Annually approximately 6.5 million U.S. patients are affected by chronic, non-healing wounds with a treatment cost estimated at $30 billion. The overall goal of their project is to meet this unmet clinical need for novel therapeutics to enhance wound healing. Specifically, the Brown team will apply their newly developed pre-polymerized colloidal fibrin-based nanoparticles that present physiologically relevant fibrin/thrombin concentrations at the wound site. Congratulations to Prof. Brown and team on this well-deserved recognition and support for their innovative translational work!